4B Technologies was selected into the final list of KPMG China Future Sector 50 Ranking Series—Biotech
On March 20, 2023, FB1001 has been granted clinical trial approval by CDE
On March 1st, 2023, the Phase I clinical trial Kick-Off Meeting of FB-1071, a category 1 new drug of 4B Technologies, was successfully held in Huashan Hospital affiliated...